Aneurysmal bone cyst treated with percutaneous doxycycline: is a single treatment sufficient?
retrospective_cohort · Level III
Where this comes from
- Record sourced from PubMed, PMID 30809704.
- Also identified by DOI 10.1007/s00256-019-03188-y.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
The purpose of this case series is to report on the effectiveness of a single percutaneous injection of doxycycline as a primary treatment for aneurysmal bone cyst (ABC). A retrospective cohort study was conducted on seven patients diagnosed with ABC at various anatomical sites, with the intention to treat by a single percutaneous injection of doxycycline. Mean patient age was 14 years. Signs of treatment response were seen in six of seven patients after one injection. Three of the seven received a second treatment, despite signs of response. Another had expansion of the lesion after treatment, requiring excision. In total, three patients had a single injection of doxycycline as their sole treatment and another three showed signs of response after a single injection. A single percutaneous injection of doxycycline should be considered a viable primary treatment option for ABC.
Medical subject headings
- Anti-Bacterial Agents
- Bone Cysts, Aneurysmal
- Doxycycline